Abstract
Background
Sepsis is a major challenge in clinical medicine, and treatment options are limited. Recently, the receptor for advanced glycation end products (RAGE) appears to be an excellent target for new therapeutic agents.
Aims
The objective of this study is to investigate the effect of small interfering RNA (siRNA) targeting RAGE on the outcome of multibacterial sepsis induced by cecal ligation and puncture (CLP) in a rat model.
Methods
A vector-based RAGE-targeted siRNA expression system (Psilencer-siRNA) was constructed and injected into rats via the jugular vein catheter after CLP injury. The RAGE expression in livers, survival rate, and plasma cytokine levels after CLP were compared between Psilencer-siRNA treated and control rats.
Results
The expression of RAGE in livers which was upregulated after CLP injury was greatly curtailed by Psilencer-siRNA administration. Compared to control rats, the Psilencer-siRNA-treated rats had significantly higher survival rate (p < 0.05) and markedly decreased plasma cytokine levels (p < 0.001) after CLP.
Conclusions
Targeting RAGE by siRNA might attenuate hyperinflammation, improve survival rate, and offer new therapeutic options for sepsis.
References
Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ et al (2013) Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 93:1247–1288. doi:10.1152/physrev.00037.2012
Gotts JE, Matthay MA (2016) Sepsis: pathophysiology and clinical management. BMJ 353:i1585. doi:10.1136/bmj.i1585
van Zoelen MA, Achouiti A, van der Poll T (2011) The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care 15:208. doi:10.1186/cc9990
Liliensiek B, Weigand MA, Bierhaus A et al (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113:1641–1650
Lutterloh EC, Opal SM, Pittman DD et al (2007) Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 11:R122
Jeong SJ, Lim BJ, Park S et al (2012) The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model. Inflamm Res 61:1211–1218. doi:10.1007/s00011-012-0518-7
McCaffrey AP, Meuse L, Pham TT et al (2002) RNA interference in adult mice. Nature 418:38–39
Pushparaj PN, Aarthi JJ, Manikandan J et al (2008) siRNA, miRNA, and shRNA: in vivo applications. J Dent Res 87:992–1003
Rittirsch D, Huber-Lang MS, Flierl MA et al (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31–36. doi:10.1038/nprot.2008.214
Lei M, Jiao H, Liu T et al (2011) siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells. Appl Microbiol Biotechnol 92:115–124. doi:10.1007/s00253-011-3371-7
Buras JA, Holzmann B, Sitkovsky M (2005) Animal Models of sepsis: setting the stage. Nat Rev Drug Discov 4:854–865
Creagh-Brown BC, Quinlan GJ, Evans TW et al (2010) The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med 36:1644–1656. doi:10.1007/s00134-010-1952-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the National Natural Scientific Foundation of China (Grant number: 81370514).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the Ethics Committee of Jinling Hospital, Medical School of Nanjing University and was performed in accordance with the Guide for Care and Use of Laboratory Animals from National Institutes of Health. This article did not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Zhao, X., Liao, Y.N. & Huang, Q. Small interfering RNA targeting receptor for advanced glycation end products protects the rats from multibacterial sepsis. Ir J Med Sci 187, 225–229 (2018). https://doi.org/10.1007/s11845-017-1613-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-017-1613-0